Assignee
NERRE THERAPEUTICS LTD
GB·8 granted patents·5 pending applications·12 citations·filing 2012–2023
Top patents by PatentIndex Score
13 records- 0187US10195205B2Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseasesNERRE THERAPEUTICS LTD·Filed 2016·Granted Feb 5, 2019·6 cites·4 claims
- 0277US9603849B2Uses of orvepitantNERRE THERAPEUTICS LTD·Filed 2013·Granted Mar 28, 2017·5 cites·5 claims
- 0371US9750739B2Orvepitant for chronic cough therapyNERRE THERAPEUTICS LTD·Filed 2016·Granted Sep 5, 2017·1 cites·11 claims
- 0466US2024108621A1Novel usesNERRE THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0563US9006271B25-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonistsNERRE THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·0 cites·13 claims
- 0662US11872222B2UsesNERRE THERAPEUTICS LTD·Filed 2021·Granted Jan 16, 2024·0 cites·11 claims
- 0760US8822504B25-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonistsNERRE THERAPEUTICS LTD·Filed 2012·Granted Sep 2, 2014·0 cites·5 claims
- 0853US2023190740A1An nk-1 receptor antagonist for treating a disease selecting from sepsis, septic shock, acute respiratory distress syndrome (ards) or multiple organ dysfunction syndrome (mods)NERRE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0951US2019216806A1Novel usesNERRE THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1049US9907795B2Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agentsNERRE THERAPEUTICS LTD·Filed 2017·Granted Mar 6, 2018·0 cites·15 claims
- 1149US8633214B2Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonistsNERRE THERAPEUTICS LTD·Filed 2012·Granted Jan 21, 2014·0 cites·6 claims
- 1246US2017326140A1Novel usesNERRE THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 1345US2017143711A1Novel usesNERRE THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NERRE THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →